Imperial College is recruiting for a new psilocybin trial aiming to treat major depression

The Psychedelic Research Group at Imperial focuses on two main research areas: 1) the action of psychedelic drugs in the brain, and 2) their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression.



The group will use fMRI to compare the treatment mechanisms of six weeks of daily Escitalopram (a SSRI antidepressant) with two doses of psilocybin. The trial commenced as of January 2019 and the team are still recruiting for participants.

If you are interested, please see if you are eligible and apply here.

DrugScience is also hosting a screening in London on 26 February of Magic Medicine, a documentary which follows participants in an earlier psychedelic study for depression run by the same group at Imperial. To find out more about the screening, please watch the trailer below, and for more information on how to get a ticket, click here